NCT07102615View on ClinicalTrials.gov

Intracervical Vasopressin

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

August 1, 2026

Study Completion Date

December 1, 2026

Conditions

Retained Products of Conception

Interventions

DRUG

Intracervical injection of Vasopressin

Intracervical injection of Vasopressin

DRUG

Intracervical Injection of saline

Intracervical Injection of saline

All Listed Sponsors

lead

Prisma Health-Upstate

OTHER